ConductScience.org, home

Paper39154013

Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.

Liu D and 8 others. Cancer Cell Int, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer. Papers, record 39154013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39154013

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.
PubMed
Journal
Cancer Cell Int
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.44, provisional
iCite
Revised in PubMed
2024-08-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu DDongze
2Qin ZZheng
3Yi BBocun
4Xie HHongbo
5Liang YYunan
6Zhu LLiang
7Yang KKuo
8Xu YYong
9Zhang HHongtuan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134936729Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer.Clin Transl Med2021https://conductscience.org/library/papers/34936729PubMed
231355524The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.Cancer Med2019https://conductscience.org/library/papers/31355524PubMed
332457745The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.Front Immunol2020https://conductscience.org/library/papers/32457745PubMed
429799499KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling.Cancers (Basel)2018https://conductscience.org/library/papers/29799499PubMed
523876621Telomerase at the intersection of cancer and aging.Trends Genet2013https://conductscience.org/library/papers/23876621PubMed
636080493Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.Molecules2022https://conductscience.org/library/papers/36080493PubMed
728052254Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.Cell Rep2017https://conductscience.org/library/papers/28052254PubMed
825691825The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.Contemp Oncol (Pozn)2015https://conductscience.org/library/papers/25691825PubMed
934987184SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer.Cell Death Differ2022https://conductscience.org/library/papers/34987184PubMed
1033754039FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts.Theranostics2021https://conductscience.org/library/papers/33754039PubMed
1135860239Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.Front Immunol2022https://conductscience.org/library/papers/35860239PubMed
1235975690TP53 loss-of-function causes vulnerability to autophagy inhibition in aggressive prostate cancer.Int J Urol2022https://conductscience.org/library/papers/35975690PubMed
1329443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
1424879116Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma.Blood Cancer J2014https://conductscience.org/library/papers/24879116PubMed
1532281273Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer.J Cell Mol Med2020https://conductscience.org/library/papers/32281273PubMed
1627692812Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH.Clin Genitourin Cancer2017https://conductscience.org/library/papers/27692812PubMed
1734370973Prostate cancer.Lancet2021https://conductscience.org/library/papers/34370973PubMed
1833446323The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer.Urol Clin North Am2020https://conductscience.org/library/papers/33446323PubMed
1921417995Telomerase: structure, functions, and activity regulation.Biochemistry (Mosc)2010https://conductscience.org/library/papers/21417995PubMed
2024979481Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24979481PubMed

See all 53 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41882722In-silico study of machine learning discovers de novo lipogenesis for predicting prognosis and immunotherapy responses in kidney renal clear cell carcinoma.Biol Direct2026https://conductscience.org/library/papers/41882722PubMed
40299459Investigating the Prognostic Role of Telomerase-Related Cellular Senescence Gene Signatures in Breast Cancer Using Machine Learning.Biomedicines2025https://conductscience.org/library/papers/40299459PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ZW109183PubTator's text mininghttps://conductscience.org/library/genes/9183

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39154013

GET https://conductscience.org/api/papers/v1/39154013/references?page=2